Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

ScienceDaily
Jul 6, 2019, 12:34 pm827 ptsInterestingTop
Some of the adverse events related to the use of regorafenib often limits its use in clinical practice. A study suggests the usefulness of a more flexible dosing, which improves patients' quality of life without jeopardizing efficacy.

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Chicago suburb deploys 27 Blue Bird electric school buses 128

Navien Brings A New Heat Pump Water Heater To Market With A Stainless Steel Tank 126

Breaking: Trump Admin Seeks To Decimate Federal Transit Funding 124

Europe’s Affordable Car Project Needs to Put the Va Va Voom into Small EVs 123

COP30 'must declare an end to ISDS’ 119

Ambitious Car CO2 Standards More Important Than Ever After Lawmakers Vote To Weaken 2040 Target 117

Hyundai is cooking up a new off-road SUV, and it sure looks electric 116

Wisconsin gets 26 new fast-charging stations with $14M of grants 112

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.